Main Street Group’s GSK GSK Stock Holding History

Main Street Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62K	Hold	50	–	–	﹤0.01%	713
2026 Q1	$2.76K	Buy	+50	New	+$2.71K	﹤0.01%	711
2025 Q4	–	Sell	-50	Closed	-$2.16K	–	303
2025 Q3	$2.16K	Hold	50	–	–	﹤0.01%	683
2025 Q2	$1.92K	Hold	50	–	–	﹤0.01%	647
2025 Q1	$1.94K	Hold	50	–	–	﹤0.01%	668
2024 Q4	$1.69K	Sell	50 -464	-90%	-$16.7K	﹤0.01%	663
2024 Q3	$21K	Hold	514	–	–	0.01%	396
2024 Q2	$19.7K	Hold	514	–	–	0.01%	411
2024 Q1	$21.8K	Buy	514 +50	+11%	+$2.06K	0.01%	421
2023 Q4	$17.2K	Buy	+464	New	+$16.7K	0.01%	669

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Main Street Group's GSK Position: Q2 2026 in Review

Main Street Group held its GSK (GSK) position steady in Q2 2026 at 50 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Main Street Group first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.8K in Q1 2024. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Main Street Group held 50 shares of GSK worth $2.62K as of Q2 2026.
Main Street Group left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #713 holding.
Main Street Group first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
Main Street Group's GSK position peaked at $21.8K in Q1 2024.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.